Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling
K. A. Levy, Zachary D. Brodnik, Jessica K. Shaw, et al.
Psychopharmacology (2017) Vol. 234, Iss. 18, pp. 2761-2776
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin‐1 receptor antagonist in rats
Morgan H. James, Hannah E. Bowrey, Colin M. Stopper, et al.
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2602-2612
Open Access | Times Cited: 64
Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation
Natalie Nevárez, Luı́s de Lecea
F1000Research (2018) Vol. 7, pp. 1421-1421
Open Access | Times Cited: 56
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine
Zachary D. Brodnik, Emily Black, Meagan J. Clark, et al.
Neuropharmacology (2017) Vol. 125, pp. 295-307
Open Access | Times Cited: 50
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction
I. Pamela Alonso, José A. Pino, Sandhya Kortagere, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 4, pp. 699-708
Open Access | Times Cited: 33
Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine
David L. Bernstein, Preeti S. Badve, Jessica R. Barson, et al.
Addiction Biology (2017) Vol. 23, Iss. 5, pp. 1032-1045
Open Access | Times Cited: 36
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats
Elahe Khosrowabadi, Saeideh Karimi‐Haghighi, Shole Jamali, et al.
Neurochemical Research (2020) Vol. 45, Iss. 9, pp. 2230-2241
Closed Access | Times Cited: 26
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights
Zachary D. Brodnik, I. Pamela Alonso, Wei Xu, et al.
Brain Research (2018) Vol. 1731, pp. 145894-145894
Closed Access | Times Cited: 27
Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin
Ernest Adeghate, Mohamed Lotfy, Crystal D’Souza, et al.
Diabetes/Metabolism Research and Reviews (2019) Vol. 36, Iss. 3
Closed Access | Times Cited: 22
Incubation of cocaine craving coincides with changes in dopamine terminal neurotransmission
I. Pamela Alonso, Bethan M. O’Connor, Kathleen G. Bryant, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100029-100029
Open Access | Times Cited: 11
Epigenetic Regulation of Circadian Clocks and Its Involvement in Drug Addiction
Lamis Saad, Jean Zwiller, Andries Kalsbeek, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1263-1263
Open Access | Times Cited: 15
Accelerated development of cocaine-associated dopamine transients and cocaine use vulnerability following traumatic stress
Zachary D. Brodnik, Emily Black, Rodrigo A. España
Neuropsychopharmacology (2019) Vol. 45, Iss. 3, pp. 472-481
Open Access | Times Cited: 16
Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys
Richard W. Foltin, Suzette M. Evans
Drug and Alcohol Dependence (2018) Vol. 188, pp. 318-327
Open Access | Times Cited: 15
Regulation of Brain DNA Methylation Factors and of the Orexinergic System by Cocaine and Food Self-Administration
Lamis Saad, Maxime Sartori, Sarah Pol Bodetto, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5315-5331
Closed Access | Times Cited: 15
Hypocretin / Orexin Receptor 1 Knockdown in GABA or Dopamine Neurons in the Ventral Tegmental Area Differentially Impact Mesolimbic Dopamine and Motivation for Cocaine
Emily Black, Shanna B. Samels, Wei Xu, et al.
Addiction Neuroscience (2023) Vol. 7, pp. 100104-100104
Open Access | Times Cited: 4
Hypocretin Receptor 1 Blockade Early in Abstinence Prevents Incubation of Cocaine Seeking and Normalizes Dopamine Transmission
P. J. Clark, Volodar M. Migovich, Sanjay Das, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability
David A. Perrey, Ann M. Decker, Yanan Zhang
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 3, pp. 587-602
Open Access | Times Cited: 10
Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats
Jessica K. Shaw, I. Pamela Alonso, Stacia I. Lewandowski, et al.
Neuropsychopharmacology (2021)
Open Access | Times Cited: 6
Novel Pharmacological Agents for the Treatment of Cocaine Use Disorder
Hasti Hadizadeh, José M. Flores, Eric J. Nunes, et al.
Current Behavioral Neuroscience Reports (2022) Vol. 9, Iss. 1, pp. 27-46
Closed Access | Times Cited: 3
The Role of Orexin Receptor Antagonists in Inhibiting Drug Addiction: A Review Article
Peyman Esmaili‐Shahzade‐Ali‐Akbari, Amir Ghaderi, Atena Sadeghi, et al.
Addiction and Health (2024) Vol. 16, Iss. 2, pp. 130-139
Open Access
Page 1 - Next Page

Scroll to top